Accelerating the Global Development of Pediatric Cancer Drugs

Aladdin - Multi-stakeholder education in drug-development

Developing new drugs for children with cancer is a complicated multi-step process that involves many different groups (academic researchers, pharmaceutical ...

Policy of pediatric oncology drug development - OUCI

... ACCELERATE drug development for paediatric cancer, Cancer Medicine, № 12, с. ... Reaman, Accelerating the global development of pediatric cancer drugs: A ...

RACE Act Increased the Number of Cancer Drugs with Required ...

“But implementation is only the beginning. It is now crucial to follow the impact of the act on pediatric oncology drug development and continue ...

Little patients, big impact: Our approach to pediatric oncology | AbbVie

In 2017, the U.S. Congress acted to support more pediatric research and treatment development by passing the RACE Act, which stands for Research ...

Filling the Federal Funding Gap | St. Baldrick's Foundation

About 60% of all funding for drug development in adult cancers comes from pharmaceutical companies. For kids? Almost none, because childhood cancer drugs are ...

Guest Blog–How Collaboration is Advancing Research and Clinical ...

The webinar will feature speakers from CAC2 and ACCELERATE Innovation for Children and Adolescents with Cancer. These two international entities ...

five years accelerating cancer drug development for children and ...

The international multi-stakeholder organisation ACCELERATE was created to advance the timely investigation of new anti-cancer drugs. ACCELERATE ...

Global Oncology Trends 2024: Outlook to 2028 - IQVIA

More than 2,000 new oncology clinical trials started in 2023 with novel modalities and significant promise for cancer treatment, including cell ...

Exposure to US Cancer Drugs With Lack of Confirmed Benefit After ...

Between 2009 and 2022, the US Food and Drug Administration (FDA) approved 48 drugs for 66 oncology-related indications under the Accelerated ...

Nepal joins the Global Platform for Access to Childhood Cancer ...

“This innovative platform will help enhance access to cancer care by addressing medicine availability issues and ensure that children who need ...

Advancing Pediatric Cancer Research and Drug Development ...

ACCELERATE is an international multistakeholder collaborative platform that brings together academia, industry, NPOs and regulators (both ...

Navigating the Regulatory Landscape to Develop Pediatric ...

Drug development for pediatric cancers has been slower than for adult cancers, and regulatory authorities in the United States and the European ...

St. Jude commits $100 million - The Cancer Letter

The initiative, St. Jude Global, aims to improve access to care for children with life-threatening diseases as well as influence the care of 30 ...

Ipsen and Day One enter into exclusive ex-U.S. licensing agreement ...

Day One Biopharmaceuticals believes when it comes to pediatric cancer, we can do better. Day One was founded to address a critical unmet need: ...

Accelerating the pace of pediatric oncology research and innovating ...

Understanding the biology of tumors to provide therapeutic innovations · Molecular profiles of tumors: better diagnoses for better treatment.

Accelerating Drug Development for Neuroblastoma - New Drug

Network for Cancer Research in Children and Adolescents (ENCCA) and the International ... development of drugs specifically for paediatric cancers. 23. Once ...

Innovations in Cancer Treatment of Children | Pediatrics

National and international efforts to enhance biospecimen banking of difficult to treat cancers is a priority. The field continues to rely on ...

5 Things to Know About the FDA RACE for Children Act

The Research to Accelerate Cures and Equity (RACE) for Children Act aims to improve and expand treatment options for pediatric cancer patients.

Regeneron Pharmaceuticals: Delivering Life-transforming Medicines

At Regeneron, we move science to medicine because our world is meant for more. ... accelerate the drug discovery and development process. More About Us.

Pediatric Cancer | JAMA Network

Explore the latest in pediatric cancers, including advances in genetic sequencing and treatment of solid and liquid tumors in children.